Literature DB >> 1084899

Requirements for induction of T cell tolerance to DNFB: efficiency of membrane-associated DNFB.

H N Claman, S D Miller.   

Abstract

Tolerance to contact sensitization with DNFB, a T cell-dependent phenomenon, was induced in mice by preparations of DNFB coupled to mouse RBC or spleen cells. Such tolerance is dose related, wanes with time, and can be transferred to normal animals with lymphoid cells (presumably containing suppressors). Tolerance to DNFB-RBC can be produced by whole DNFB-RBC, by ghosts of these cells, by sonicates of the ghosts, and by detergent-treated DNFB-RBC ghosts. Tolerance cannot be produced by larger amounts of DNFB-RBC components not associated with membrane. The ability of various DNP compounds to stimulate DNA synthesis in DNFB-sensitized cells also correlates with their ability to bind to protein components; i.e., DNFB is a far more efficient stimulator than DNBSO, whereas DNPlysine does not stimulate at all. Thus, the ability to sensitize or to tolerize with DNFB congeners is related to their ability to couple to proteins. It appears that the active induction of T cell tolerance requires that tolerogen be coupled to cell membranes. Since both T cell sensitization and tolerance to DNFB are best produced by DNFB-membrane, the actual occurrence of one state or the other must depend on the molecular method of "presentation" of DNFB-membrane.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1084899

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis.

Authors:  Ada Yeste; Meghan Nadeau; Evan J Burns; Howard L Weiner; Francisco J Quintana
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-27       Impact factor: 11.205

2.  Immune reactions in the eye.

Authors:  C S Foster; R Wetzig
Journal:  Surv Immunol Res       Date:  1982

3.  Antigen- and receptor-driven regulatory mechanisms. II. Induction of suppressor T cells with idiotype-coupled syngeneic spleen cells.

Authors:  M S Sy; B A Bach; A Brown; A Nisonoff; B Benacerraf; M I Greene
Journal:  J Exp Med       Date:  1979-11-01       Impact factor: 14.307

4.  Contact sensitivity and tolerance induction to DNFB in experimental dengue virus infection.

Authors:  M Nagarkatti; P S Nagarkatti
Journal:  Immunology       Date:  1980-06       Impact factor: 7.397

5.  Inhibition of the anti-receptor antibody response of contact sensitivity by interferon.

Authors:  W Freitag; J Knop
Journal:  Immunology       Date:  1985-06       Impact factor: 7.397

6.  Induction of tolerance by haptenated liposomes carrying mouse erythrocyte membrane glycoprotein.

Authors:  Y Hitsumoto; T Hineno; S Utsumi
Journal:  Immunology       Date:  1984-12       Impact factor: 7.397

7.  Genetic restrictions for the induction of suppressor T cells by hapten-modified lymphoid cells in tolerance to 1-fluoro-2,4-dinitrobenzene contact sensitivity. Role of the H-2D region of the major histocompatibility complex.

Authors:  S D Miller; M S Sy; H N Claman
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

8.  The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells.

Authors:  S D Miller; R P Wetzig; H N Claman
Journal:  J Exp Med       Date:  1979-03-01       Impact factor: 14.307

9.  Antigen- and receptor-driven regulatory mechanisms. III. Induction of delayed type hypersensitivity to azobenzenearsonate with anti-cross-reactive idiotypic antibodies.

Authors:  M S Sy; A R Brown; B Benacerraf; M I Greene
Journal:  J Exp Med       Date:  1980-04-01       Impact factor: 14.307

10.  Soluble factors in tolerance and contact sensitivity to 2,4-dinitrofluorobenzene in mice. III. Histocompatibility antigens associated with the hapten dinitrophenol serve as target molecules on 2,4-dinitrofluorobenzene-immune T cells for soluble suppressor factor.

Authors:  J W Moorhead
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.